Crystallization of meloxicam in the presence of hydrophilic additives to tailor its physicochemical and pharmaceutical properties

[1]  A. Nokhodchi,et al.  The use of cooling and anti-solvent precipitation technique to tailor dissolution and physicochemical properties of meloxicam for better performance , 2020 .

[2]  S. Mortazavi,et al.  Fabrication and In-vitro Evaluation of Buccal Mucoadhesive Tablet of Meloxicam , 2020, Iranian journal of pharmaceutical research : IJPR.

[3]  S. Emami,et al.  Electrosprayed Nanosystems of Carbamazepine – PVP K30 for Enhancing Its Pharmacologic Effects , 2018, Iranian journal of pharmaceutical research : IJPR.

[4]  J. Rantanen,et al.  Role of Solvent Selection on Crystal Habit of 5-Aminosalicylic Acid-Combined Experimental and Computational Approach. , 2017, Journal of pharmaceutical sciences.

[5]  D. Arango,et al.  Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin , 2017 .

[6]  A. Doriguetto,et al.  Analysis of polymorphic contamination in meloxicam raw materials and its effects on the physicochemical quality of drug product , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  W. Beckmann,et al.  Particle Engineering of an Active Pharmaceutical Ingredient for Improved Micromeritic Properties , 2017 .

[8]  Rita Ambrus,et al.  Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  M. Farhangi,et al.  Biodegradable Gelatin Microspheres as Controlled Release Intraarticular Delivery System: The Effect of Formulation Variables , 2017 .

[10]  S. Al-Nimry,et al.  Preparation and Optimization of Sertraline Hydrochloride Tablets with Improved Dissolution Through Crystal Modification , 2017, AAPS PharmSciTech.

[11]  M. El-Nabarawi,et al.  Particle engineering/different film approaches for earlier absorption of meloxicam , 2016, Drug delivery.

[12]  R. Ambrus,et al.  The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam , 2016, Molecules.

[13]  Sung-Joo Hwang,et al.  Enhancement of dissolution and bioavailability of ezetimibe by amorphous solid dispersion nanoparticles fabricated using supercritical antisolvent process , 2015, Journal of Pharmaceutical Investigation.

[14]  M. Ochi,et al.  Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability , 2015, AAPS PharmSciTech.

[15]  A. Bansal,et al.  Effect of surfactant concentration on nifedipine crystal habit and its related pharmaceutical properties , 2015 .

[16]  Waseem Kaialy,et al.  An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression. , 2014, International journal of pharmaceutics.

[17]  N. Jain,et al.  Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. , 2013, Chemistry and physics of lipids.

[18]  M. Rao,et al.  Nanocrystallization by Evaporative Antisolvent Technique for Solubility and Bioavailability Enhancement of Telmisartan , 2012, AAPS PharmSciTech.

[19]  Miranda L. Cheney,et al.  Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation. , 2012, Molecular pharmaceutics.

[20]  K. R. Reddy,et al.  Preparation of meloxicam spherical agglomerates to improve dissolution rate , 2012 .

[21]  Miranda L. Cheney,et al.  Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics. , 2011, Journal of pharmaceutical sciences.

[22]  R. Tan,et al.  Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. , 2011, International journal of pharmaceutics.

[23]  Siling Wang,et al.  Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[24]  Eunbi Cho,et al.  Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives. , 2010, International journal of pharmaceutics.

[25]  J Kristl,et al.  Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam. , 2009, International journal of pharmaceutics.

[26]  V. Boldyrev,et al.  Synthesis of co-crystals of meloxicam with carboxylic acids by grinding , 2009 .

[27]  R. Tan,et al.  Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. , 2009, International journal of pharmaceutics.

[28]  J. Rantanen,et al.  Crystal Morphology Engineering of Pharmaceutical Solids: Tabletting Performance Enhancement , 2009, AAPS PharmSciTech.

[29]  K. Pathak,et al.  Solid dispersion of meloxicam: Factorially designed dosage form for geriatric population , 2008, Acta pharmaceutica.

[30]  R. Rajkó,et al.  Preparation of a Solid Dispersion by a Dropping Methodto Improve the Rate of Dissolution of Meloxicam , 2008 .

[31]  D. Mishra,et al.  Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000. , 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[32]  M. Fathy,et al.  Enhancement of the Dissolution and Permeation Rates of Meloxicam by Formation of Its Freeze-dried Solid Dispersions in Polyvinylpyrrolidone K-30 , 2006, Drug development and industrial pharmacy.

[33]  A. Nokhodchi,et al.  Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives , 2005 .

[34]  N. Rodríguez-Hornedo,et al.  Growth and Morphology of L-Alanine Crystals: Influence of Additive Adsorption , 1993, Pharmaceutical Research.

[35]  Chan‐Wha Kim,et al.  Microcrystallization of indomethacin using a pH-shift method. , 2003, International journal of pharmaceutics.

[36]  M. Fornai,et al.  Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug , 2002 .

[37]  A. Nokhodchi,et al.  The effect of solvent and crystallization conditions on habit modification of Carbamazepine , 2001 .

[38]  J. Sherwood,et al.  Crystallization of paracetamol from solution in the presence and absence of impurity. , 2001, International journal of pharmaceutics.

[39]  A. Tiwary,et al.  Modification of Crystal Habit and Its Role in Dosage Form Performance , 2001, Drug development and industrial pharmacy.

[40]  M. H. Rubinstein,et al.  Highly compressible paracetamol: I: crystallization and characterization. , 2000, International journal of pharmaceutics.

[41]  J. Dressman,et al.  In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[42]  P. Schoenfeld.  Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials. , 1999, The American journal of medicine.